Neonatal hemolytic jaundice: Morphologic features of erythrocytes that will help you diagnose the underlying condition

Neonatology

Volumn 105, Issue 4, 2014, Pages 243-249

  Christensen, Robert D ^a,b   Yaish, Hassan M ^a,b   Lemons, Richard S ^a,b  

^a INTERMOUNTAIN HEALTHCARE   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Erythrocyte; Glucose 6 phosphate dehydrogenase; Hemolysis; Jaundice; Kernicterus; Neonate

Indexed keywords

BITE CELL; BLISTER CELL; BLOOD; CELL STRUCTURE; CELL TYPE; ECHINOCYTE; ELLIPTOCYTE; ERYTHROCYTE; ERYTHROCYTE MEMBRANE; GENE MUTATION; GENE SEQUENCE; HEMOLYSIS; HUMAN; MICROSPHEROCYTE; NEONATAL HYPERBILIRUBINEMIA; NEONATOLOGIST; NEWBORN; NEWBORN HEMOLYTIC DISEASE; NEWBORN JAUNDICE; PRIORITY JOURNAL; REVIEW; TECHNOLOGY; BLOOD EXAMINATION; ERYTHROCYTE DISORDER; GENETIC PREDISPOSITION; GENETICS; HYPERBILIRUBINEMIA, NEONATAL; JAUNDICE, NEONATAL; MICROSCOPY; PATHOLOGY; PREDICTIVE VALUE; PROGNOSIS; RISK FACTOR; SEVERITY OF ILLNESS INDEX; BLOOD GROUP ABO INCOMPATIBILITY; ELLIPTOCYTOSIS; ENZYME DEFICIENCY; ERYTHROCYTE STRUCTURE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HEALTH CARE COST; HEMANGIOMA; HEMOLYTIC UREMIC SYNDROME; HEREDITARY SPHEROCYTOSIS; HYPERBILIRUBINEMIA; JAUNDICE; KERNICTERUS; MORPHOLOGY; NEWBORN CARE; NEWBORN SEPSIS; PERINATAL ASPHYXIA; PROTEIN C DEFICIENCY; THROMBOCYTOPENIA; THROMBOTIC THROMBOCYTOPENIC PURPURA; VASCULAR TUMOR;

ERYTHROCYTES, ABNORMAL; GENETIC PREDISPOSITION TO DISEASE; HEMATOLOGIC TESTS; HEMOLYSIS; HUMANS; HYPERBILIRUBINEMIA, NEONATAL; INFANT, NEWBORN; JAUNDICE, NEONATAL; MICROSCOPY; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLYCOLYTIC ENZYME; HEMOGLOBIN; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

EID: 84893683831     PISSN: 16617800     EISSN: 16617819     Source Type: Journal    
DOI: 10.1159/000357378     Document Type: Review

References (42)

1. Bhutani VK, Stark AR, Lazzeroni LC, Poland R, Gourley GR, Kazmierczak S, Meloy L, Burgos AE, Hall JY, Stevenson DK: Initial clinical testing evaluation and risk assessment for universal screening for hyperbilirubinemia Study Group. Predischarge screening for severe neonatal hyperbilirubinemia identifies infants who need phototherapy. J Pediatr 2013; 162: 477-482.e1.
2. Bhutani VK, Stevenson DK: The need for technologies to prevent bilirubin-induced neurologic dysfunction syndrome. Semin Perinatol 2011; 35: 97-100.
3. Christensen RD, Lambert DK, Henry E, Eggert LD, Yaish HM, Reading NS, Prchal JT: Unexplained extreme hyperbilirubinemia among neonates in a multihospital healthcare system. Blood Cells Mol Dis 2013; 50: 105-109.
4. Johnson L, Bhutani VK, Karp K, Sivieri EM, Shapiro SM: Clinical report from the pilot USA kernicterus registry (1992 to 2004). J Perinatol 2009; 29:S25-S45.
5. Kaplan M, Muraca M, Hammerman C, Rubaltelli FF, Vilei MT, Vreman HJ, Stevenson DK: Imbalance between production and conjugation of bilirubin: a fundamental concept in the mechanism of neonatal jaundice. Pediatrics 2002; 110:e47-e49.
6. Maisels MJ, Kring E: The contribution of hemolysis to early jaundice in normal newborns. Pediatrics 2005; 118: 276-279.
7. Kaplan M, Muraca M, Vreman HJ, Hammerman C, Vilei MT, Rubaltelli FF, Stevenson DK: Neonatal bilirubin production-conjugation imbalance: effect of glucose-6-phosphate dehydrogenase deficiency and borderline prematurity. Arch Dis Child Fetal Neonatal Ed 2005; 90:F123-F127.
8. Zanella A, Bianchi P, Fermo E: Pyruvate kinase deficiency. Haematologica 2007; 92: 721-723.
9. Mohandas N, Gallagher PG: Red cell membrane: past, present, and future. Blood 2008; 112: 3939-3948.
10. Christensen RD, Nussenzveig RH, Yaish HM, Henry E, Eggert LD, Agarwal AM: Identifying causes of significant hyperbilirubinemia in neonates using 'next generation' gene sequencing. 2013, submitted.
11. Gallagher PG, Glader B: Hereditary spherocytosis, hereditary elliptocytosis, and other disorders associated with abnormalities of the erythrocyte membrane; in Greer JP, Foerster J, Rodgers GM, Paraskevas F, Glader B, Arber DA, Means RT Jr (eds): Wintrobe's Clinical Hematology, ed 12. Philadelphia, Lippincott/Williams & Wilkins, 2009, pp 911-932.
12. Bruce LJ: Hereditary stomatocytosis and cation-leaky red cells-recent developments. Blood Cells Mol Dis 2009; 42: 216-222.
13. Chavez-Bueno S, Beasley JA, Goldbeck JM, Bright BC, Morton DJ, Whitby PW, Stull TL: Haptoglobin concentrations in preterm and term newborns. J Perinatol 2011; 31: 500-503.
14. Cakmak A, Calik M, Atas A, Hirfanoglu I, Erel O: Can haptoglobin be an indicator for the early diagnosis of neonatal jaundice J Clin Lab Anal 2008; 22: 409-414.
15. Yaish HM, Henry E, Baer VL, Bennett ST, Christensen RD: A simple method of screening newborn infants for hereditary spherocytosis. J Appl Hematol 2013;4: 27-32.
16. Herschel M, Karrison T, Wen M, Caldarelli L, Baron B: Isoimmunization is unlikely to be the cause of hemolysis in ABO-incompatible but direct antiglobulin test-negative neonates. Pediatrics 2002; 110: 127-130.
17. Christensen RD, Yaish HM, Nussenzveig RH, Reading NS, Agarwal AM, Eggert LD, Prchal JT: Acute kernicterus in a neonate with O/B blood group incompatibility and a mutation in SLC4A1. Pediatrics 2013; 132:e531-e534.
18. Yaish HM, Christensen RD, Agarwal A: A neonate with Coombs-negative hemolytic jaundice with spherocytes but normal erythrocyte indices: a rare case of autosomal-recessive hereditary spherocytosis due to -spectrin deficiency. J Perinatol 2013; 33: 404-406.
19. Hoffmann JJ, Swaak-Lammers N, Breed WP, Strengers JL: Diagnostic utility of the pre-incubated acidified glycerol lysis test in haemolytic and non-haemolytic anaemias. Eur J Haematol 1991; 47: 367-370.
20. Kar R, Mishra P, Pati HP: Evaluation of eosin-5-maleimide flow cytometric test in diagnosis of hereditary spherocytosis. Int J Lab Hematol 2010; 32: 8-16.
21. Christensen RD, Henry E: Hereditary spherocytosis in neonates with hyperbilirubinemia. Pediatrics 2010; 125: 120-125.
22. King MJ, Zanella A: Hereditary red cell membrane disorders and laboratory diagnostic testing. Int J Lab Hematol 2013; 35: 237-243.
23. Christensen RD, Nussenzveig RH, Reading NS, Agarwal AM, Prchal JT, Yaish HM: Variations in both -spectrin (SPTA1) and -spectrin (SPTB) in a neonate with prolonged jaundice in a family where nine individuals had hereditary elliptocytosis. Neonatology 2014; 105: 1-4.
24. Yoo D, Lessin LS: Drug-associated 'bite cell' hemolytic anemia. Am J Med 1992; 92: 243-248.
25. Mishriki YY: What's eating these red blood cells Drug-induced 'bite-cell' hemolytic anemia. Postgrad Med 1998; 104: 45-46.
26. Bender JW, Reilly MP, Asakura T: Molecular stability and function of hemoglobins Hasharon (2 47 (CD5)Asp-His- 2 ) and Hasharon (2 47 (CD5)Asp-His-2 ). Hemoglobin 1984; 8: 61-73.
27. Christensen RD, Yaish HM, Wiedmeier SE, Reading NS, Pysher TJ, Palmer CA, Prchal JT: Neonatal death suspected to be from sepsis was found to be kernicterus with G6PD deficiency. Pediatrics 2013; 132:e1694-e1698.
28. Kaplan M, Beutler E, Vreman HJ, Hammerman C, Levy-Lahad E, Renbaum P, Stevenson DK: Neonatal hyperbilirubinemia in glucose-6-phosphate dehydrogenase-deficient heterozygotes. Pediatrics 1999; 104: 68-74.
29. Christensen RD, Yaish HM, Johnson CB, Bianchi P, Zanella A: Six children with pyruvate kinase deficiency from one small town: molecular characterization of the PK-LR gene. J Pediatr 2011; 159: 695-697.
30. Zini G, d'Onofrio G, Briggs C, Erber W, Jou JM, Lee SH, McFadden S, Vives-Corrons JL, Yutaka N, Lesesve JF; International Council for Standardization in Haematology (ICSH): ICSH recommendations for identification, diagnostic value, and quantitation of schistocytes. Int J Lab Hematol 2012; 34: 107-116.
31. Motta M, Del Vecchio A, Radicioni M: Clinical use of fresh-frozen plasma and cryoprecipitate in neonatal intensive care unit. J Matern Fetal Neonatal Med 2011; 24(suppl 1): 129-131.
32. Lotta LA, Garagiola I, Palla R, Cairo A, Peyvandi F: ADAMTS13 mutations and polymorphisms in congenital thrombotic thrombocytopenic purpura. Hum Mutat 2010; 31: 11-19.
33. Schiff DE, Roberts WD, Willert J, Tsai HM: Thrombocytopenia and severe hyperbilirubinemia in the neonatal period secondary to congenital thrombotic thrombocytopenic purpura and ADAMTS13 deficiency. J Pediatr Hematol Oncol 2004; 26: 535-538.
34. Camilleri RS, Scully M, Thomas M, Mackie IJ, Liesner R, Chen WJ, Manns K, Machin SJ: A phenotype-genotype correlation of ADAMTS13 mutations in congenital thrombotic thrombocytopenic purpura patients treated in the United Kingdom. J Thromb Haemost 2012; 10: 1792-1801.
35. Salonvaara M, Kuismanen K, Mononen T, Riikonen P: Diagnosis and treatment of a newborn with homozygous protein C deficiency. Acta Paediatr 2004; 93: 137-139.
36. Fallahpour M, Hafizi A, Fouladgar A, Rajabian B: Neonatal atypical hemolytic uremic syndrome may cause prenatal asphyxia. Arch Iran Med 2012; 15: 729-730.
37. Besbas N, Gulhan B, Karpman D, Topaloglu R, Duzova A, Korkmaz E, Ozaltin F: Neonatal onset atypical hemolytic uremic syndrome successfully treated with eculizumab. Pediatr Nephrol 2013; 28: 155-158.
38. Menni F, Testa S, Guez S, Chiarelli G, Alberti L, Esposito S: Neonatal atypical hemolytic uremic syndrome due to methylmalonic aciduria and homocystinuria. Pediatr Nephrol 2012; 27: 1401-1405.
39. Laurence J: Diagnosis of atypical hemolytic uremic syndrome: a review of case studies. Clin Adv Hematol Oncol 2012; 10(suppl 17): 9-11.
40. Yohannan MD, Abdulla AM, Patel PJ: Neonatal hepatic haemangioendothelioma: presentation with jaundice and microangiopathic haemolytic anaemia. Eur J Pediatr 1990; 149: 804-805.
41. Cosgrove DM, Fisher M, Gabow P, Gottlieb G, Halvorson GC, James BC, Kaplan GS, Perlin JB, Petzel R, Steele GD, Toussaint JS: Ten strategies to lower costs, improve quality, and engage patients: the view from leading health system CEOs. Health Aff (Millwood) 2013; 32: 321-327.
42. Perkins SL: Examination of the blood smear; in Greer JP, Foerster J, Rodgers GM, Paraskevas F, Glader B, Arber DA, Means RT Jr (eds): Wintrobe's Clinical Hematology, ed 12. Philadelphia, Lippincott/Williams & Wilkins, 2009, pp 9-10.